(Given the potential long-term consequences of NMOSD relapses, the company could not ethically include a direct placebo arm in its Phase III trial.) Ultomiris was well-tolerated overall, and most treatment-emergent events were mild or moderate in severity, according to AstraZeneca
This antioxidant binds to toxins, heavy metals, and waste products, converting them into a form that can be easily excreted from the body
For first-time users, start at 0.6mg per dose to monitor for side effects, and if appetite suppression is insufficient, gradually increase the dose each week by 0.6mg up to a maximum of 3.0mg
Price NL, Gomes AP, Ling AJ, et al
Sun C, Hu SH, Dong BQ, Jiang S, Miao F, Lei TC
10.2147/DDDT.S332847 84 HeY.FangD.LiangT.PangH.NongY.TangL.et al (2021b)